News > J&J is right on track to launch its Covid-19 vaccine, says executive
J&J is right on track to launch its Covid-19 vaccine, says executive
The Hindu Business Line | 27/01/2021 01:55 PM | Click to read full article
Johnson & Johnson’s top executive said that the company is “comfortable” meeting its 2021 supply commitments for the Covid-19 vaccine. J&J is currently prepping for regulatory filings and formulating plans for the global rollout of its vaccine after publishing phase 3 trial results.
If the data are positive, that could meaningfully accelerate the rollout of vaccinations across the US and potentially disrupt other vaccine manufacturers’ demand expectations.